 |
Recognizing and Treating Androgen Deficiency Syndrome in Aging Men CME/CE Author Information and Disclosures Release Date: January 31, 2008; Valid for credit through January 31, 2009 | Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians;
Nurses - 1.0 nursing contact hours (0.5 contact hours are in the area of pharmacology);
Pharmacists - 1.0 ACPE continuing education credits for pharmacists (0.1 CEUs) | | To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details. Contents of This CME/CE Activity Legal DisclaimerThe material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © 2008 Medscape. |
|
|
Learning Objectives Upon completion of this activity, participants will be able to: - Discuss the pathophysiology of late-onset hypogonadism.
- Review the clinical manifestations of hypogonadism, including common comorbidities such as type 2 diabetes, obesity, and the metabolic syndrome.
- Review the clinical
diagnosis of hypogonadism by means of patient history, questionnaires, and appropriate laboratory testing.
- Describe the treatment of late-onset hypogonadism, including the various types of testosterone-replacement therapy and safety issues.
Authors and Disclosures Ronald S. Swerdloff, MD
Disclosure: Ronald S. Swerdloff, MD,
has disclosed that he has received grants from Acrux, Ardana, Ascend, Auxillium, Bristol-Myers Squibb, Clarus, GlaxoSmithKline, Indevus, Lilly, National Institutes of Health, Organon, Solvay Pharmaceuticals, and Repros. Dr. Swerdloff has also disclosed that he has served as a consultant to Acrux, Ardana, Ascend, Auxillium, Clarus, Corcept, GlaxoSmithKline, Indevus, Pierre Fabre, Solvay Pharmaceuticals, and Repros, and has served as a speaker for Auxillium and Solvay
Pharmaceuticals. Christina Wang, MD
Disclosure: Christina Wang, MD, has disclosed that she has received grants for clinical research from Acrux, Ardana, Bristol-Myers Squibb, Clarus, GlaxoSmithKline, Indevus, and Solvay, and that she has served as an advisor or consultant to GlaxoSmithKline, Indevus, and Solvay. David McNeel
Disclosure: David McNeel has
disclosed no relevant financial relationships. |
 |
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Contact This Provider
|
|
This Activity is sponsored by Medscape Continuing Education Provider Unit. Medscape is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.
Awarded 1.0 contact hour(s) of continuing nursing education for RNs and APNs; 0.5 contact hours are in the area of pharmacology. Provider Number: 6FDKKC-PRV-05
Contact This Provider
|
|
 Medscape is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Medscape designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) (Universal Program Number 461-000-08-003-H01-P).
Contact This Provider
|
|
